LIMITATIONS AND DEFICIENCIES OF PHARMACO-ECONOMIC STUDIES IN THE RUSSIAN FEDERATION COMMENTS TO THE ARTICLE OF S. L. PLAVINSKIY ET AL. «PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS»
.
Saved in:
| Main Author: | D. N. Protsenko |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
New Terra Publishing House
2017-11-01
|
| Series: | Вестник анестезиологии и реаниматологии |
| Online Access: | https://www.vair-journal.com/jour/article/view/61 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
PHARMACOECONOMIC ANALYSIS OF THE IMPACT ON THE BUDGET COSTS OF ADDING DEXMEDETOMIDINE (DEXDOR) INTO THE LIST OF VITAL AND ESSENTIAL DRUGS
by: S. L. Plavinskiy, et al.
Published: (2017-11-01) -
RETRACTED: Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research
by: V. V. Ryazhenov, et al.
Published: (2022-06-01) -
PHARMACOECONOMICS AS A NEW INSTRUMENT OF PHARMACEUTICAL MARKETING
by: M. V. Protsenko, et al.
Published: (2015-03-01) -
Retraction of the article: Ryazhenov V.V., Gorokhova S.G., Bunyatyan N.D. Opportunities of the method «Budget impact analysis» for performing pharmacoeconomic research
by: article Editorial
Published: (2022-07-01) -
Pharmacoeconomics of chronic kidney disease
by: R. I. Yagudina, et al.
Published: (2018-02-01)